Simplification of Insulin Regimen in Older Adults and Risk of Hypoglycemia
Hypoglycemia is a serious adverse event, especially in older patients with diabetes, and is associated with poor outcomes. 1 Intensive insulin regimens add a large burden of self-care to older patients and increase the risk of hypoglycemia. 2, 3 Treatment guidelines and expert consensus recommend deintensification of treatment regimens in older adults. 4 However, the effect of insulin regimen simplification on the risk of hypoglycemia or uncontrolled hyperglycemia is not known. In addition, the lack of an algorithm to guide insulin regimen simplification may account for missed opportunities to deintensify insulin regimens in older patients with diabetes. 5 Methods | In a single-arm, intervention study, we recruited 65 adults 65 years or older, with type 2 diabetes (positive stimulated serum C-peptide levels) on 2 or more insulin injections/d with 1 or more episodes of hypoglycemia (≤70 mg/dL) over a 5-day period of continuous glucose monitoring (CGM). Simplification was achieved by switching multiple-dose insulin regimens to once-a-day glargine with or without noninsulin agents over a 5-month period, followed by a 3-month nocontact (no interaction with study staff) period to assess sustainability of the simplified regimen. The algorithm used to simplify the regimen included adding and/or changing longacting insulin to basal insulin glargine, decreasing and discontinuing meal-time insulin, and simultaneously adding noninsulin agents (Figure) . 6 improved at 5 months and remained low at 8 months (P < .001). Interestingly, the duration of hypoglycemia was not different when subjects were stratified by HbA 1c levels of less than 7.0%, 7.1% to 8.0%, 8.1% to 9.0%, and more than 9.0% at baseline (mean duration, 278 min/5-day CGM), 5-month (mean duration, 124 min/5-day CGM), or 8-month (mean duration, 88 min/5-day CGM).
Results |
Discussion | Our results show that insulin regimen simplification can reduce the risk of hypoglycemia without compromising glycemic control. After simplification, 36 (60%) of the study patients only needed 1 additional agent with basal insulin, 23 (38%) needed 2 agents, and 1 (2%) needed 3 agents. In addition, the total dose of the insulin was significantly reduced after simplification. An important benefit of 
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